GLPwatch
Trials (2167)
Page 15 of 37.
- Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
- Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes
- Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients
- Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
- Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
- A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- RISE Adult Medication Study
- Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
- A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice
- Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
- The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity
- Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
- GLP-1 and Microvascular Function in Type 2 Diabetes
- Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
- A Study of LY3437943 in Participants With Type 2 Diabetes
- Tirzepatide for the Treatment of Cannabis Use Disorder
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
- Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
- Liraglutide and Heart Failure in Type 2 Diabetes
- Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
- Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
- Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
- A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
- A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity
- A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
- Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus
- Digital Physical Activity Program
- A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
- Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
- A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
- Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
- Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes
- Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
- GLP-1/Basal Insulin Combination Therapy
- Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
- Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
- Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
- The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
- Semaglutide and Preoperative Residual Gastric Volumes
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
- A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)
- A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
- Oat Flakes β-glucan on Glycemic Variability, Pancreatic Reserve, and Dyslipidemia Among Adolescents With Type 1 Diabetes
- Liraglutide Use in Prader-Willi Syndrome
- Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
- Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
- Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
- A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
- Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity
- Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms
- Effects of Exenatide on Hypothalamic Obesity
- Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
- Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
- Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity
- A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
- Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight